BioCentury
ARTICLE | Company News

Biovica, Karolinska Institute deal

February 15, 2016 8:00 AM UTC

The companies partnered to evaluate the efficacy of two 7,8-dihydro-8-oxoguanine triphosphatase ( NUDT1; MTH1) inhibitor cancer therapies from the institute using Biovica’s DiviTum assay. DiviTum mea...